Recent Finacing
Recent Raise
iPierian develops monoclonal antibody therapeutics for neurodegenerative diseases using patient-derived iPSC platforms to discover and advance tau-targeted and broader neurodegeneration drug candidates.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
